Evidence map›Paper›PMID 41815535›Full record

ArticleNature catalysis2024

Merging photoredox with metalloenzymatic catalysis for enantioselective decarboxylative C(sp

Jinyan Rui, Xinpeng Mu, Jordi Soler, Jared C Paris, Yisong Guo, Marc Garcia-Borràs, Xiongyi Huang

Abstract read
In one paragraph

Article in Nature catalysis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Examining Pseudohalide (NJournal of inorganic biochemistry · 2026
    Article
  10. Article
  11. Protein engineering: status report.Protein engineering, design & selection : PEDS · 2026
    Review
  12. Designing and Engineering Enzymes for New-to-Nature Photobiocatalysis.Methods in molecular biology (Clifton, N.J.) · 2026
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Enantioconvergent benzylic C(spScience (New York, N.Y.) · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jinyan RuiDepartment of Chemistry, Johns Hopkins University, Baltimore, MD 21218, USA.
Xinpeng MuDepartment of Chemistry, Johns Hopkins University, Baltimore, MD 21218, USA.
Jordi SolerInstitut de Química Computacional i Catàlisi (IQCC) and Departament de Química, Universitat de Girona, Campus Montilivi, Girona E-17071, Catalonia, Spain.
Jared C ParisDepartment of Chemistry, Carnegie Mellon University, Pittsburgh, PA 15213, USA.
Yisong GuoDepartment of Chemistry, Carnegie Mellon University, Pittsburgh, PA 15213, USA.
Marc Garcia-BorràsInstitut de Química Computacional i Catàlisi (IQCC) and Departament de Química, Universitat de Girona, Campus Montilivi, Girona E-17071, Catalonia, Spain.
Xiongyi HuangDepartment of Chemistry, Johns Hopkins University, Baltimore, MD 21218, USA.

Funding

Elucidate Mechanisms of Quinolone Alkaloid Biosynthesis via Iron(II)/2-Oxoglutarate Dependent Enzymes: Diverse, but Controlled ReactivityR01GM125924 · NIGMS · CARNEGIE-MELLON UNIVERSITY · PI Yisong Guo · 2018 to 2026
$3.3M
NIGMS NIH HHS R01 GM125924
6 · The paper itself

Abstract

The scope of nature's catalytic abilities has been expanded by recent advancements in biocatalysis to include synthetic transformations with no biological equivalent. However, these newly introduced catalytic functions only represent a small fraction of reactions utilized in synthetic catalysis. This study presents a biocatalytic platform that combines photoredox and metalloenzymatic catalysis for enantioselective radical transformations. Under green light irradiation, the eosin Y photocatalyst enables 4-hydroxyphenylpyruvate dioxygenases (HPPD) to catalyse enantioselective decarboxylative azidation and thiocyanation of

Identifiers

PMID41815535
PMCPMC12974898

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.